Latest Breaking News On - Peter pechan - Page 1 : comparemela.com

Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.  AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.

United statesStephen bassoInozyme pharmaPhelps mcnamaraR michael carruthersSynageva biopharmaPeter pechanSierk poettingJens hoslteinLucio tozziBradley gloverBristol myers squibbMark pennesiGuy levyEvelo biosciencesTyler ralston